As the bidding window closes today, December 24, the Gujarat Kidney and Super Speciality IPO has wrapped up its journey in the primary market on a confident note. By mid-day on Day 3, the issue had already sailed past full subscription, reflecting steady investor participation across categories, with retail investors taking the lead.
From the market’s lens, the momentum around this IPO has been building quietly over the past three days. What started as cautious interest has now turned into broad-based participation, especially from individual investors tracking healthcare sector listings.
Market Performance: Subscription Status at a Glance
By 1:30 pm on the final day of bidding, the Gujarat Kidney and Super Speciality IPO was subscribed over 4 times (410%) of its total offer size.
Here’s how the demand stacked up:
- Total bids received: ~5.43 crore shares
- Total shares on offer: 1.32 crore shares
- Overall subscription: Over 4x
Category-wise participation highlights where the interest came from:
- Retail Individual Investors (RII):
Subscribed nearly 16 times (1,579%), clearly driving the issue’s demand. - Non-Institutional Investors (NII):
Booked over 4.5 times (455%) of their reserved portion. - Qualified Institutional Buyers (QIB):
Subscribed 58% of their allocated quota so far.
The numbers indicate that retail and high-net-worth participation played a key role in pushing the IPO into oversubscription territory.
Main News: Gujarat Kidney and Super Speciality IPO Details
The Gujarat Kidney and Super Speciality IPO is a Rs 250.80 crore public issue, structured entirely as a fresh issue of up to 2.20 crore equity shares. There is no offer-for-sale (OFS) component in this IPO.
This structure means:
- All funds raised from the IPO will go directly to the company
- No existing shareholders are selling their stake through this issue
Key IPO Dates and Price Band
- Price band: Rs 108–114 per share
- Issue opening date: December 22
- Issue closing date: December 24
- Basis of allotment: Likely by December 29
- Listing date: Tentatively December 30
- Stock exchanges: BSE and NSE
Minimum Investment Requirement
- Minimum lot size: 128 shares
- Investment at upper band: Rs 14,592
- Bids allowed in multiples of the lot size thereafter
Anchor Book: Early Institutional Participation
Ahead of the public opening, the company completed its anchor investor process on December 19, raising over Rs 100 crore.
- Equity shares allotted to anchors: 87.73 lakh
- Issue price: Upper band of the price range
Major allocations included:
- Craft Emerging Market Fund (via Citadel Capital Fund and Elite Capital Fund):
39.47 lakh shares worth Rs 45 crore - Khandelwal Finance:
13.16 lakh shares for Rs 15 crore - Venus Investments:
8.77 lakh shares for Rs 10 crore
The anchor participation helped set the tone for the IPO ahead of the public bidding phase.
Company Details: Healthcare Footprint in Gujarat
Gujarat Kidney and Super Speciality operates within the healthcare services space, with a strong regional presence.
As of now, the company runs:
- 7 multi-speciality hospitals
- 4 pharmacies
- Total bed capacity: 490 beds
- Primary operations: Within the state of Gujarat
The company focuses on providing specialty healthcare services through its hospital network, supported by pharmacy operations.
Use of IPO Proceeds
The company has clearly outlined how the fresh issue proceeds will be deployed. The funds are spread across acquisitions, expansion, equipment purchase, and general corporate needs.
Breakup of fund utilisation:
- Rs 77 crore:
Acquisition of Parekhs Hospital, Ahmedabad - Rs 12.4 crore:
Part-payment for the already acquired Ashwini Medical Centre - Rs 10.78 crore:
Acquisition of additional stake in subsidiary Harmony Medicare - Rs 30.09 crore:
Setting up a new hospital in Vadodara - Rs 6.8 crore:
Purchase of robotics equipment - Rs 1.2 crore:
Partial debt repayment - Remaining amount:
Inorganic growth initiatives and general corporate purposes
Merchant Banker to the Issue
- Merchant banker: Nirbhay Capital Services
Summary: What the Subscription Data Tells Us?
The Gujarat Kidney and Super Speciality IPO closes with strong subscription numbers, led by retail and non-institutional investors. Oversubscription of over 4 times by the final day highlights consistent demand, especially in the retail segment.
With a fully fresh issue structure, clearly defined use of proceeds, and a healthcare-focused business operating across Gujarat, the IPO’s progress through the subscription phase reflects steady market participation rather than sudden spikes.
As the focus now shifts to allotment and listing, the Gujarat Kidney and Super Speciality IPO marks another closely tracked healthcare listing in the primary market calendar.
Source: Moneycontrol
Easy & quick
Leave A Comment?